Resources

This fact sheet provides an update to Medicare eligibility arrangements for magnetic resonance imaging (MRI) equipment from 1 July 2025 as well as answers to frequently asked questions about these changes.

This page provides information about changes to capital sensitivity provisions for diagnostic imaging services from 1 July 2024.

The National Strategy for Radiation Safety (the National Strategy) has been developed in partnership with the states and territories. It aims to develop a consistent approach to radiation protection across Australia.

Use this form to apply for an exemption from capital sensitivity where there are unforeseen delays to replace/upgrade diagnostic imaging equipment.

This fact sheet outlines the conditions required for MRI machines to be Medicare-eligible, and the services that can be provided on full and partial Medicare-eligible MRI machines.

This report summarises the main results of the Reducing Overuse of Diagnostic Imaging project. We collaborated with the Wiser Healthcare research consortium on this project .

Fact sheet and quick reference guide on changes to the Medicare Benefits Schedule (MBS) diagnostic imaging items and rules.

This fact sheet explains the Medicare Benefits Schedule (MBS) changes to eligibility for Magnetic Resonance Imaging (MRI) equipment.

This fact sheet outlines the difference between a request and a referral.

This fact sheet outlines information about 2 new Medicare Benefits Schedule (MBS) items for patients with prostate cancer.

This fact sheet outlines changes to capital sensitivity arrangements for diagnostic imaging from 1 May 2022.

This fact sheet outlines the updated interpretations of the rules for personal attendance for musculoskeletal ultrasound and personal supervision for positron emission tomography (PET) imaging service during COVID-19.

A Budget 2022–23 fact sheet.

This fact sheet outlines information about Medicare Benefits Schedule (MBS) substitution item 61644 for use during the thallium-201 supply shortage.

Use this form if you are a requester or provider of diagnostic imaging (DI) or pathology services and want to let us know about another person who has asked for or accepted or
offered or provided a prohibited benefit, or made a threat.

This user guide and its appendices outline how to apply for the Diagnostic Imaging Accreditation Scheme.

These literature reviews were used to help develop BreastScreen Australia’s position on the use of digital breast tomosynthesis in breast screening, assessment and diagnosis.

This guideline outlines what you can do to substantiate a service to be requested by another medical practitioner for Medicare Benefits Schedule (MBS) items 57521 and 65070.

This guide aims to clarify how the laws relating to pathology and diagnostic imaging affect both requesters and providers of pathology and diagnostic imaging services.

This guideline outlines what you can do to substantiate diagnostic imaging and pathology services rendered to emergency department patients of public hospitals and claimed under Medicare.